Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 10 April 2025 - 14:20

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised

Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts

Submitted by Anonymous (not verified) on 10 April 2025 - 12:02

Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts

Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA

Submitted by Anonymous (not verified) on 10 April 2025 - 8:32

Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness